0 CHECKOUT

PRODUCT FILTERS

REGION

95
20
17
16
16

COUNTRY

13
6
2
2
1

CATEGORIES

  • 127
  • 85
  • 73
  • 65
  • 60
  • 39
  • 27
  • 25
  • 20
  • 16
  • 14
  • 13
  • 13
  • 10
  • 10
  • 9
  • 9
  • 9
  • 9
  • 8
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

243
259
308
456

PUBLISHED

3
19
76
456

PRODUCT TYPE

221
156
53
15
5
3
2
1

Search for: "Antiviral Drugs - DUPLICATE"

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

Published:  June 2016
Price:  From

Competitor Analysis: Dengue Virus Vaccines, Antibodies & Antivirals

This Competitive Intelligence Report provides a competitor evaluation in the field of approved and investigational vaccines and therapeutics against one or more stereotypes of Dengue Virus for prophylaxis...

Published:  February 2016
Price:  From

Antivirals - Global Strategic Business Report

This report analyzes the worldwide markets for Antivirals in US$ Million The major product segments analyzed are HIV Antivirals (Reverse Transcriptase Inhibitors (RTIs) (Nucleotide Reverse Transcriptase...

Published:  October 2006
Price:  From

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth Summary GBI Research in its present report ”Generics...

Published:  June 2012
Price:  From

Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market

GBI Research, the leading business intelligence provider, has released its latest research “Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics...

Published:  April 2012
Price:  From

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)

This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials...

Published:  February 2012
Price:  From

The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape

The global anti-infective market is currently valued at US$66 5 billion with antiviral agents accounting for 24% of sales (excluding vaccines which target viral infectious diseases) According to our...

Published:  May 2007
Price:  From

Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets

Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets Summary GBI Research has released its latest research “Antivirals Market to...

Published:  January 2011
Price:  From

The World Market for Anti-infectives Volume III: The World Market for Antiviral Medications

This report analyzes the world markets for human antiviral medications, focusing on the current market for and the development of drugs that are used to directly combat and treat viruses viral infections....

Published:  April 2003
Price:  From

Competitor Analysis: Antiviral Antibodies

This report, as of July 2008, provides a competitor analysis in the development pipeline of novel antibodies against viral infections such as hepatitis C virus (HCV), hepatitis B virus, SARS coronavirus,...

Published:  July 2008
Price:  From

Anti-Infectives: World Market, 2nd Edition, Vol III: Antivirals

This third volume of Kalorama Information’s World Market for Anti-Infectives series, the 2nd. Edition focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease...

Published:  May 2007
Price:  From

The World Market for Anti-Infectives, Volume III: Antivirals

This volume of Kalorama Information’s World Market for Anti-Infectives series focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The...

Published:  June 2005
Price:  From

Market for Antiviral Therapeutics and Vaccines

This report from Kalorama Information examines the burgeoning antiviral market, and provides a comprehensive analysis of both therapeutics and vaccines: AIDS and HIV therapeutics; hepatitis therapeutics...

Published:  January 1996
Price: 

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they...

Published:  October 2009
Price:  From

The World Market for Anti-infectives Series: Volumes I - III - Antifungals, Antibacterials and Antivirals

Once a public health problem pegged for easy elimination, infectious diseases continue to be the leading cause of death worldwide. Despite improved methods of treating and preventing infection, including...

Published:  April 2003
Price:  From

Antiviral Drug Strategies, Volume 50. Methods and Principles in Medicinal Chemistry

New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need...

Published:  April 2011
Price: 

Antiviral Drugs. From Basic Discovery Through Clinical Trials

A complete, one–stop reference to real–world antiviral drug discovery and development The field of antiviral drugs continues to evolve at a fast pace in response to new virus discoveries and development...

Published:  July 2011
Price: 

Advances in Antiviral Drug Design, Vol 5

Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses...

Published:  July 2007
Price: 

Global Infectious Disease Treatment Market 2014-2018

About Infectious Disease Treatment Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one...

Published:  August 2014
Price:  From

Advances in Antiviral Drug Design, Vol 4

The fourth volume of Advances in Antiviral Drug Design is keeping up with the recent progress made in the broad field of antiviral drug research and encompasses six specific directions that have opened...

Published:  December 2003
Price: 
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation